A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies

This study has been terminated.
Sponsor:
Information provided by:
Exelixis
ClinicalTrials.gov Identifier:
NCT00475917
First received: May 17, 2007
Last updated: October 1, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: May 2009
  Estimated Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)